Clinical Trial Update: Melanil in the Treatment of Melasma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Melanil for the treatment of melasma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Melanil

Snippet

Sponsor: Catalysis SL | Conditions: Melasma | Phase 3 | Status: COMPLETED